Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects
Clinical trial NCT04165837 · COMPLETED
Trial details
- NCT number
- NCT04165837
- Sponsor
- 1ST Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-14
- Primary completion
- 2021-11-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.